Nuclear Medicine: Page 107

Lantheus touts clinical results for cardiac PET agent

By AuntMinnie.com staff writers

Lantheus Holdings is highlighting new data showing that its investigational flurpiridaz F-18 PET radiopharmaceutical agent for myocardial perfusion imaging (MPI) is superior to MPI with SPECT in patients with suspected heart disease undergoing stress testing.

September 22, 2016

Navidea gets $1M for 2 Lymphoseek milestones

By AuntMinnie.com staff writers

Navidea Biopharmaceuticals will receive payments totaling $1 million for fulfilling two commercial milestones for its Lymphoseek radiopharmaceutical.

September 21, 2016

Bruker to buy Oncovision's preclinical business

By AuntMinnie.com staff writers

Bruker said it has signed an agreement to acquire the preclinical imaging business of Spanish medical technology developer Oncovision. Terms of the transaction were not disclosed.

September 14, 2016

Report warns of shortages to Mo-99 supply in U.S.

By Wayne Forrest

Supplies of a key radioisotope used in nuclear cardiology scans could be disrupted next month when a Canadian nuclear reactor begins shutting down. U.S. healthcare providers could be left scrambling for new sources of molybdenum-99 (Mo-99) until other suppliers are able to step in and fill the void.

September 12, 2016

UAE steps up campaign on dose awareness

By Frances Rylands-Monk

Moves to limit medical radiation exposure are intensifying in the United Arab Emirates (UAE), and safety issues and education now are high on the agenda of healthcare professionals. Every effort must be made to reduce exposure and boost risk awareness, according to key participants at next month's summit in the region.

September 12, 2016

NorthStar hires 2 new VPs

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has hired two new vice presidents: James Brodack, PhD, will become vice president of regulatory affairs/quality assurance and Rim Milunas will become vice president of engineering.

September 11, 2016